companies / inbrain-neuroelectronics-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-22 json
| total_raised | 46,440,00046.4M | ○ |
|---|---|---|
| founded | null | |
| hq | Barcelona | |
| industry | unknown | |
| stage | series-b+ |
Inbrain Neuroelectronics develops graphene-based implantable brain-computer interfaces that decode and modulate neural networks to treat neurological disorders. It targets patients with conditions like Parkinson's disease and epilepsy, along with their treating clinicians. Its graphene electrodes reach up to 1024 contact points for higher signal resolution at lower power than conventional neural implants, and it holds FDA Breakthrough Device Designation.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-01-01 | series-b | 46,440,00046.4M | null | ○ |
Nginx, WordPress 7.0, Yoast SEO 21.8, Flockler, Slick, jQuery Migrate 3.4.1, jsDelivr, Plesk, Contact Form 7 5.8.6, Python, PHP, MySQL
| fact | status | src |
|---|---|---|
| Series B, $46.4M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |